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Background
Disease surveillance is a scientifically and legally estab-
lished hallmark of population health whose goal is sys-
tematically collecting, interpreting and disseminating
data to target and monitor interventions to reduce dis-
ease morbidity and mortality [1–5]. However, data is
often either lacking or of low quality especially in low-
and- middle-income countries (LMICs). For example,
more than half of global deaths for 2015 did not have an
established cause [6]. The Global Burden of Disease
(GBD), the largest descriptive epidemiological study,
show low rates of data quality for most LMICs during
1980–2016 [7]. Despite substantial improvements in data
quality and cause of death establishment [8, 9], of over
50 health-related Sustainable Development Goals
(SDGs) indicators identified in the World Health Statis-
tics 2017 report, data is adequate for monitoring 36 indi-
cators [10].
Lack of, and low, quality data is exacerbated by data
inconsistencies between sources often due to different
methodologies of data gathering, synthesis and report-
ing. For example, data from the GBD, differs significantly
with data from the World Health Organization (WHO)
[11, 12] and HIV estimates from national surveillance
systems in high-income countries and UNAIDS [13]. In
low-income countries (LICs) data from demographic
and population surveys differ even within the same re-
gion for similar periods of time [14, 15]. Even when
there are strategies in place like the Integrated Disease
Surveillance and Response (IDSR) strategy for reporting
communicable diseases in the WHO African region,
they are poorly implemented [16, 17]. Discrepancies and
gaps have led to a call for better data in recent years,
e.g., by former WHO Secretary General [18], and subse-
quent development of Guidelines for Accurate and
Transparent Health Estimates Reporting (GATHER) to
define and promote best reporting practices for popula-
tion studies in global and local contexts [19].
Without good data evidence-based public health deci-
sions and interventions cannot be made [18, 20].
Current global burden of disease assessment shows mul-
tiple epidemiological transitions with rising
non-communicable diseases (NCDs) and decreasing in-
fectious diseases in prevalence, morbidity and mortality
[6, 7]. In 2016, 54.7 million people died of which 72.3%
were from NCDs and 8.4% from communicable, mater-
nal, neonatal, and nutritional conditions (CMNN) [7].
Comprising 61.4% of 2.4 billion disability-adjusted
life-years (DALYs) in 2016 [21], mortality from NCDs
has risen 16.1% during 2006–2016 [7] and could reach
52 million by 2030 [22, 23]. On the other hand, mortal-
ity from all CMNN conditions including HIV/AIDS, tu-
berculosis, malaria and diarrheal diseases have declined
over the same period by 24% overall [7]. Some LICs like
Ethiopia have seen more dramatic decreases of up to
65% during 1990–2015 [24]. Although CMNN condi-
tions remain a challenge, the decreases have resulted
from key breakthroughs in prevention, treatment and
control [25].
WHO data shows that 86% of deaths due to NCDs are
in LMICs and most are premature [22]. Among these,
cardiovascular diseases (CVDs), diabetes and cancer are
the major killers [26]. With 8.2 million deaths and 14.1
million new cases in 2012, cancers are the single leading
cause of world-wide deaths with 70% of the deaths oc-
curring in LMICs [27, 28]. As the primary cause of
CVD, hypertension is the leading risk factor for morbid-
ity affecting 24% of adult men and 20% of adult women
or 1.13 billion adults globally in 2015 [29]. Leading risk
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factors shared among the major NCDs – tobacco use,
harmful consumption of alcohol, unhealthy diet, and
physical inactivity – are all highly modifiable to prevent
nearly half of premature NCD deaths [30–33].
Among LMIC regions, sub-Saharan Africa (SSA) faces
the greatest challenge from NCDs that could pose the
next ‘poverty trap’ [34]. While carrying the largest bur-
den of major communicable diseases such as malaria,
HIV/AIDS, tuberculosis, and neglected tropical diseases
(NTDs) [35–38], the subcontinent is also undergoing
critical epidemiological, demographic and socio-
economic transformations including nutrition transitions
that are resulting in a rise in NCDs such as cancer,
hypertension, obesity and diabetes as earlier predicted
[29, 39–44].An ageing and increasing population with
simultaneously increasing number of people living with
diseases like tuberculosis and HIV poses other chal-
lenges for NCD comorbidities [41, 44–49]. For example,
a systematic review and meta-analytical study observed
accelerated risk of pre-diabetes and diabetes among
HIV-positive users of antiretroviral treatment (ART) due
to ageing, dyslipidemia, metabolic syndrome, obesity and
some ART medications that cause mitochondrial toxicity
in long term use [50]. These effects have implications
for the WHO recommendation to start ART treatment
with initial HIV positivity test [51]. Owing to these pat-
terns of disease, the case to invest more in health in Af-
rica has been made by key global health agencies and
key players on the continent including the WHO, the
World Bank and the African Union [52].
Taking action on NCDs would save millions of lives
and save LMICs an estimated $7 trillion in economic
loses during 2011–2025 [22]. The growing prominence
of NCDs led to the 2011 political declaration by the
United Nations [53, 54]. Following this the WHO devel-
oped a Global Monitoring Framework for NCDs with
nine voluntary targets to reduce mortality due to NCDs
by 25% by 2025 [55], a target set to one third by 2030 in
the SDG framework [56]. Towards this, surveillance data
for NCDs are critically needed to inform interventions
for the Global Action Plan for the Prevention and Con-
trol of NCDs 2013–2020 [32]. Recent reviews of ap-
proaches to data gathering for NCDs in LMICs find
limited capacities and systems [3, 8, 57–59]. The ap-
proaches range from population and demographic sur-
veys, vital registration systems, and socio-economic,
behavioural and utilization surveys. Among the major
approaches is the STEPwise approach to surveillance
(STEPS) developed by the WHO in 2002 [60].
STEPS is a standardized NCD surveillance protocol in-
volving three different levels of steps to gather
self-reported data on demographics and behavioural risk
factors physical and biochemical measures from nation-
ally representative populations [60]. Since initiation the
STEPS protocol has undergone multiple revisions given
increasing body of knowledge and to serve the NCDs
Global Monitoring Framework [61]. With over 120
countries implementing STEPS, it is the most widely
used approach to collect data on NCDs and assess popu-
lation risk-factor profiles to inform, monitor and evalu-
ate policies and interventions [60, 61]. In the WHO
African region 41 countries have implemented the
STEPS. Here we summarize results of the Kenya STEPS
appearing in this special journal supplement as captured
in ten separate articles. We first overview the STEPS
method followed by a summary of key findings in each
article and then discuss these findings in context of their
implications for NCDs surveillance and policy.
Surveillance of NCDs through the STEPS in Kenya
Prior to the STEPS, national data on NCDs and related
risk factors could have been estimated from the Kenya
Demographic and Health Survey (KDHS), the 2014
Kenya Global Adult Tobacco Survey (GATS), the 2003
Global School Health Survey on physical inactivity and
the GBD studies, and more recently the NCD Risk Fac-
tor Collaboration [29]. Covering numerous countries,
the DHS Program started collecting data on NCDs by
including a blood pressure module in 1998 [57]. In
Kenya, the first DHS was conducted in 1989 but the
NCD module was only added in the latest (2014) survey.
The KDHS covers cancer and hypertension as well as
three NCD risk factors (tobacco use, alcohol consump-
tion, and physical inactivity), all of which are
self-reported [62]. The GBD estimated that the contribu-
tion of NCDs to health loss (DALYs) amounted to 19.4%
in 2000 rising to about 30% in 2013 [63]. Although the
DHS uses a nationally representative sample and the
GDB aggregates multiple data sources [57], these reports
do not match the depth of measures, methodology and
risk-factor analysis capabilities of the STEPS. Aside from
the national DHS, NCD data for Kenya are also captured
in rural-regional demographic surveys in western Kenya
[64] and in the coastal region [65], and in the limited
Nairobi cancer registry [66]. In addition, the first Global
school-based student health survey (GSHS) was con-
ducted in 2003 [67] and the first Global Tobacco Survey
(GTS) in 2014 [68].
These and other disease-specific studies have provided
knowledge of NCDs in Kenya as well as risk factors but
the prevalence of diseases, their distribution and
risk-factors at the national level have not been compre-
hensively examined. The DHSs have provided evidence
that NCDs are prevalent not just in urban but also in
rural areas and are rising [64, 65] while estimates based
on the cancer registry indicate cancer contributes to 7%
of national mortality [66, 69]. A unique study using the
health production function estimated the effect of risk
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factors for NCDs based on national household expend-
iture and health utilization data [70]. Key risk factors to
NCDs were socio-economic (income, education levels),
health systems (e.g., distance to health facilities, cost of
care), adverse social interactions in area of residence
(e.g., availability and consumption of alcohol and smok-
ing and influencing behavioural factors), and biological
factors (e.g., age and gender) [70]. The STEPS has
allowed a deeper and more comprehensive understand-
ing of the national NCDs risk-factor profile.
Overview of methods for the Kenya STEPS
The STEPs Kenya 2015 survey was a national
cross-sectional household survey conducted between
April and June 2015. It was designed to provide esti-
mates for indicators on risk factors for NCDs for per-
sons aged 18–69 years with a sample size of 6,000
individuals to allow national estimates by sex (male and
female) and residence (urban and rural areas). Using a
three-stage sampling, 200 clusters (100 urban and 100
rural) were selected in stage one, followed by a uniform
selection of 30 households in each cluster in stage two,
and in stage three one adult aged 18–69 years was ran-
domly selected from each household, with a household
defined as people who eat and live together, and
approached for the survey. The survey used the fifth Na-
tional Sample Surveys and Evaluation Programme (NAS-
SEP V) master sample frame that is developed and
maintained by Kenya National Bureau of Statistics. The
stratified probability proportional to size sampling meth-
odology was developed using 96,251 Enumeration Areas
(EAs) generated from the 2009 Kenya Population and
Housing Census to form 5,360 clusters split into four
equal sub-samples [62]. National sampling frames are
necessary for disease surveillance at the household level
and evolve over time to reflect population and adminis-
trative changes [71]. The Kenya STEPS thus uses the
most recent frame (NASSEP V) which was also used in
the latest DHS.
The survey used the modular expanded STEPS collect-
ing demographic and behavioural information (step 1),
physical measurements (step 2) and biochemical mea-
sures (step 3) [60]. After providing informed consent,
the participants were interviewed on the four main be-
havioural risk factors of NCDs (tobacco use, harmful use
of alcohol, unhealthy diets, and physical inactivity), and
measurements for key biological risk factors for NCDs
(overweight and obesity derived from height and weight
and central obesity derived from waist and hip circum-
ference, blood pressure and fasting blood glucose, trigly-
ceride, and cholesterol levels) were also taken. The
survey was administered using a Personal Digital Assist-
ant (PDA) loaded with the WHO eSTEPS software. Data
collection took place during a two-month period (April–
June) in 2015. Complete details of the sample design,
methodology and questionnaire are provided in the for-
mal report published by the Ministry of Health [72].
Each article also summarizes specific methodological
method for the relevant question covered.
Research ethics approval for the Kenya STEPS was ob-
tained from Kenya Medical Research Institute (SSC No.
2607). The survey was funded by the World Bank, but
the Bank had no role in the decision to publish this spe-
cial issue nor in interpretation of the results.
Overview of the results of the Kenya STEPS
The ten individual articles covering the Kenya STEPS
data reports the following main findings, without any
specific order.
Mohamed and colleagues’ paper on hypertension fo-
cuses on the prevalence, awareness, treatment and con-
trol including determinants. The study reveals that the
age-standardized prevalence for hypertension in Kenya
was 24.5% which is similar to the global average [29] but
lower than rest of sub-Saharan Africa at 30% [73].
Among those with hypertension 15.6% were aware of el-
evated blood pressure, of whom 26.9% were on treat-
ment and 51.7% of those on treatment had achieved
blood pressure control. Key factors associated with
hypertension were older age, higher body mass index
(BMI) and harmful use of alcohol, all of which are char-
acteristic factors in other populations.
Another article by Mohamed and other colleagues
analyses data on prevalence and factors associated with
pre-diabetes and diabetes mellitus, finding the
age-standardized prevalence at 3.1% and 2.4%, respect-
ively. Nearly half (43.7%) were aware of having
pre-diabetes or diabetes, a figure that is worse than the
global estimate of undiagnosed diabetes of 50% but bet-
ter than the Africa estimate of 69% [74]. About 20%
were on treatment and only 7% of these had achieved
glycaemic control. Low level of education was associated
with lower odds of pre-diabetes while raised blood pres-
sure, overweight/obesity among women, and older age
(60–69 years) were associated with diabetes.
The article on cervical cancer looks at predictors of
cervical cancer screening among women. Among 1,180
women interviewed only 16.4% had screened for cervical
cancer despite high awareness (67.9% of unscreened
women) of cervical cancer screening. Predictors of
screening were higher education levels, being in the
highest income quintile and living in urban areas.
Wekesah et al. analyze factors associated with the
presence of multiple NCD risk factors at the individual
and household levels. Key findings show that over two
thirds (75.8%) of individuals in this study had four to six
risk factors for NCDs and 10% had seven or more risks.
Insufficient fruit and intake was almost universal
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(99.8%). The overwhelming majority (89.5% and 80.3%,
respectively) consumed high dietary salt and had insuffi-
cient physical activity. The number of NCD risk factors
increased with age among both men and women and
household wealth index status. Associations of risks with
other socio-demographic factors such as income-level,
marital status, ethnicity and region differed between
sexes. For example, married women had higher odds of
more NCD risk factors.
Analysis of risk factors for NCDs and injury adds an-
other perspective from the Kenya STEPS data. Using a
K-median cluster analysis approach the article develops
a risk profile of the population identifying five clusters
for NCDs (hypertensives, harmful users, the hopefuls,
the obese, and the fat lovers) and four clusters for injury
(helmet users, jaywalkers, the defiant and the compliant).
The strongest predictors of clustering were age, gender,
education and wealth index. The article’s key message is
that different portions of the population are exposed to
differing risk factors creating the diverse risk profiles.
Identifying these risk profiles is critical and confirms
that policy formulation and interventions for injuries in
particular and NCDs in general need to be differently
targeted to mitigate exposure to risk factors, thus priori-
tizing a “best buys” approach.
The prevalence and the determinants of heavy episodic
drinking (HED) were assessed by Kendagor and colleagues.
Overall adult HED prevalence was determined to be 12.6%
with men comprising 88.5% of this group. The 18–29 years
old age group had the highest proportion (35.5%) of HED.
HED was also high (60%) among the married/cohabiting
but even higher among those who were separated.
Home-brewed beers or wines were the most commonly re-
ported by almost two thirds of the respondents. Consump-
tion of tobacco was associated with higher odds of HED
but the years of schooling, wealth quintile and residence
did not have any effect on HED prevalence.
Levels and determinants of tobacco use is the focus of
the article by Ngaruiya et al. Tobacco use was reported
by 13.5% of the respondent sample of which 83.8% of
users were men. Among the users 78.8% did so daily.
The average age of starting tobacco use was 21 years
and 75% of users were less than 50 years old and mostly
in the 18–29 year-old age group. On the other hand, the
50–59 year age group were three times more likely to
use tobacco daily than the younger age groups. Being
male, adolescent/youth, and having lower level of educa-
tion were the main determinants of tobacco use. Major-
ity (71.7%) of users had no schooling beyond primary
school. Tobacco smoking was more common in urban
areas compared to rural areas where smokeless tobacco
use was more predominant. Alcohol use had a moderate
association on daily tobacco use. An insignificant num-
ber reported using e-cigarettes.
Assessing the prevalence and predictors of physical in-
activity Gichu et al.’s study finds very low levels of phys-
ical inactivity with only 7.7% of respondents being
classified as physically inactive. Being female and of mid-
dle age (30–49 years), and having higher education and
income levels (middle wealth quintile) were the most
important predictors of physical inactivity with area of
residence (urban/rural) having little prediction effect.
Mwenda and co-authors analyse patterns of dietary
risk factors and association with NCDs. Results show
that high (unhealthy) intake of dietary salt and sugar was
18.3% and 13.7%, respectively. The majority of respon-
dents were aware of health risk from dietary salt (88%)
and sugar (91%) although just over half were implement-
ing steps to reduce intake of salt and sugar (56% and
54% of respondents, respectively). Daily intake of a mini-
mum of five servings of both fruits and vegetables was
reported by only 6.0% the respondents. Male gender, be-
ing under 46 years old and being a student were strongly
associated with unhealthy diet.
Gathecha and colleagues examine prevalence and pre-
dictors of injuries. Prevalence of injuries over past
12 months was 15.2% and 60.3% were males. The main
causes of injuries were falls (47.6%), cuts (34.0%) and
road traffic crashes (4%). Injuries due to violent incident
was only reported by 3.7% of respondents. Injuries were
significantly more prevalent among rural residents and
40.7% occurred at home, 16.9% in the farm and 16.7% in
other work places. Consistent seatbelt use among drivers
and passengers was reported by only 12.5%, 62% of
motorcycle users never use helmets and drunk driving
was reported by 8.1% of the drivers. Younger males age
18–29 years and smokers were significantly more likely
to be injured in a road traffic accident. Binge drinking
was a factor in violent incidents as was age 30–39 years.
Being in the top two income quintiles was protective
against unintentional injuries.
Discussion
These studies from the Kenya STEPS provide the most
comprehensive understanding of NCDs and associated
risk factors in the country. To a large degree the results
reflect the current stage of demographic and economic
transitions. Overall, according to data from the KDHS
deaths due to NCDs increased from 35% of total deaths
in 2003 to 45% in 2010 [64]. In 2018, Kenya’s population
is estimated at 50.9 million with 72.9% living in rural
areas [48]. After dipping due to the HIV/AIDS crisis in
the 1990s, life expectancy has been increasing since
2000 as transitions continue to occur in health and the
economy with a growing urbanization and an expanding
middle class [41].
Correspondingly, levels of physical inactivity, over-
weight/obesity nutrition transitions reflect population
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distribution and economic activity. For example, physical
inactivity in the STEPS was only 7.7% compared with
that in other higher income-level countries like South
Africa (44.7%) and Swaziland (49.1%) and the global
prevalence of 31% [75]. Without strong culturally miti-
gating effects, disease transition models predict these de-
velopments to continue to create a society where NCDs
dominate commensurate with the dominant risk factor
environment [39, 41, 76–79]. For that reason, Kenya
needs to vigorously take measures to meet the goals laid
out in the Global Action Plan for the Prevention and
Control of NCDs 2013–2020 [32], the country’s Vision
2030 for a healthy and prosperous nation [80], and the
SDG #3 target 4 of reducing premature mortality due to
NCDs by one third by 2030 [81].
The health effects of NCDs and related risk-factors are
well established [33, 82–86]. As the Kenya STEPS data
show, socio-economic and demographic factors namely,
income level, age, gender, urban residence and education
are associated with NCDs [70, 72]. Taking action on
NCDs would save millions of lives and economic prod-
uctivity [34, 87, 88]. The WHO estimated that just $11.2
billion in annual investments could save $7 trillion in
lost productivity in LMICs during 2011–2025 [22]. As
such, interventions for NCDs are highly cost-effective.
For example, nutrition education in New York City pub-
lic schools was cost-effective in reducing childhood
obesity [89]. Effective policy changes are also
cost-effective and will decrease NCD costs and preva-
lence making it the best way to improve overall health
for all [90]. Addressing factors contributing to excessive
weight gain; smoking and treating hypertension would
be cost-effective in tackling NCDs in Kenya [41].
Health benefits resulting from reducing risks for
NCDs are huge. Increased longevity resulting from posi-
tive change in lifestyle is evident even in older adults
aged over 50 years with or without CVDs [83]. Large na-
tionally representative data in the US has recently shown
that, compared to the status quo, maintaining a healthy
BMI, eating a healthy diet, a moderate use of alcohol,
and moderate to vigorous exercise could add over a dec-
ade of life for men and women over 50 years of age [85].
Interventions to target one risk factor can often have
cascading effects. For example, because physical inactiv-
ity is shown to contribute to numerous NCDs including
cancer and approximately 30% of ischaemic heart dis-
ease [84] programs to increase physical activity could
have huge effects.
Kenya has a national strategy for prevention and con-
trol of NCDs for 2015–2020 [91]. A new cancer control
strategy for 2017–2022 was recently launched [92]. In
addition, the country also has strong policies on smok-
ing and alcohol, namely the Framework Convention for
Tobacco Control (FCTC) which the country ratified in
2004, the Kenya Tobacco Control Act of 2007 and the
2010 Alcoholics Drinks Control Act. Despite these pol-
icies, laws and strategies, capacity to document, imple-
ment, monitor, and evaluate NCD programming in the
country as in other LMICs is woefully inadequate
[57, 58]. In the 2014 WHO NCDs Country Profiles,
Kenya reported negative to having any of the nine national
systems to respond to NCDs [93]. The latest (2013) Kenya
Service Availability and Readiness Assessment Mapping
(SARAM) showed that overall only 5% of facilities offered
all NCD services defined in the Kenya Essential Package
of Health (KEPH) and only 25% of health facilities had dif-
ferent tracer commodities for NCDs with huge regional
variations [94]. Strengthening core data for NCDs in vital
registration and integrating risk-factor surveillance into
policy and programming is essential [59]. Because of com-
plex challenges in standardization experts recommend
utilization of mixed data systems, a practice currently in
place everywhere although some countries have more ro-
bust structures than others [3, 57, 59].
This special journal issue of the Kenya STEPs survey
brought numerous co-author teams together drawn from
the Kenya Ministry of Health, the African Population and
Health Research Centre (APHRC), other entities and aca-
demia both locally and abroad. Altogether, 35 comprising
scholars and practitioners in many disciplinary fields con-
tributed to the special issue. The 10 research articles were
peer-reviewed by a team of 22 reviewers and 3 editors from
different disciplines and institutions around the world. The
publication demonstrates the value for international collab-
orations in research on NCDs. Such collaborations provide
opportunities but also challenges [95]. In our case,
inter-institutional and interdisciplinary north-south and
south-south collaborations were key strengths. Such collab-
orations provide benefits for science, academic and imple-
menting institutions, and for the individual investigators. In
an era where team research is increasingly promoted [96]
true collaborations could help improve equity in inter-
national health research and increase output by African
scholars and practitioners [97, 98]. To our knowledge this
is the first time any country has organized to publish com-
prehensive STEPS data in a special issue in the
peer-reviewed literature.
Conclusions
The 2015 Kenyan STEPS survey provides the first snap-
shot of major NCDs risk factors burden in the country,
serving as baseline against which future progresses will be
monitored. Such monitoring should include a repetition
of the survey at regular time-intervals. The scope of NCDs
and risk factors is too broad to be comprehensively cov-
ered in a single survey, including in high-income coun-
tries. However, by strategically building into successive
surveys, specific modules for key NCDs/risk factors,
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countries over time are able to generate surveillance data
for major established and emerging NCDs in their popula-
tion. Kenya could use a similar approach in future STEPS
or similar surveys, to expand the scope of traditional NCD
risk factors to lipid disorders including expanding the as-
sessment of diabetes beyond a fasting glucose level that is
likely to underestimate the prevalence, to collect data on
neglected NCDs like epilepsy and mental health, and on
emerging and novel risk factors. This should ideally go in
parallel with efforts to develop and maintain complemen-
tary data sources, which in the long term, will equip the
country with a comprehensive surveillance system for
NCDs. With such a pragmatic policy prescription for
NCD surveillance, the country also need to step up
provision of services for prevention and treatment of
NCDs in and outside the health system in line with na-
tional and global goals. Ultimately, for Kenya and coun-
tries across Africa the path to longer and healthier lives to
2030 [99], and beyond, requires understanding disease
profiles matched by the right interventions.
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